(a-D-mannosyl)2-b-D-mannosyl-N-acetylglucosamine

Metabolite details

Identifier

ANPUOEHHKRCFGW-NRDBFSGKSA-N

InChI Key

ANPUOEHHKRCFGW-NRDBFSGKSA-N

IUPAC name

N-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6S)-4-[(2R,3R,4R,5S,6S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

Preferred name

(a-D-mannosyl)2-b-D-mannosyl-N-acetylglucosamine

INN name

—

Synonym

—

ChEBI

CHEBI:188319

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• High complexity and diel dynamics of planktonic microbiome revealed by multi-omics in Taihu, China
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• 2:00 AM_Membrane_vs_2:00 AM_Net
• Male_19_days_vs_Male_1_day
• Male_19_days_vs_Male_1_day